H J Smith

990 total citations
69 papers, 815 citations indexed

About

H J Smith is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, H J Smith has authored 69 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 26 papers in Genetics and 18 papers in Organic Chemistry. Recurrent topics in H J Smith's work include Estrogen and related hormone effects (26 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Retinoids in leukemia and cellular processes (8 papers). H J Smith is often cited by papers focused on Estrogen and related hormone effects (26 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Retinoids in leukemia and cellular processes (8 papers). H J Smith collaborates with scholars based in United Kingdom, Singapore and United States. H J Smith's co-authors include Paul J. Nicholls, Claire Simons, Richard L. Irwin, Michael Shaw, A.W. Wheeler, Janet M. Dewdney, Rhys Whomsley, Robert D. E. Sewell, M. J. E. Hewlins and Andrew J. Kirby and has published in prestigious journals such as Nature, Journal of Clinical Microbiology and Journal of Medicinal Chemistry.

In The Last Decade

H J Smith

67 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H J Smith United Kingdom	17	314	283	258	162	132	69	815
Timothy J. Maziasz United States	15	255 0.8×	190 0.7×	320 1.2×	718 4.4×	220 1.7×	21	1.4k
Mark C. Walker United States	18	473 1.5×	115 0.4×	354 1.4×	438 2.7×	104 0.8×	32	1.2k
Earl G. Burton United States	16	339 1.1×	88 0.3×	217 0.8×	281 1.7×	125 0.9×	26	956
Victor Kenyon United States	16	451 1.4×	108 0.4×	248 1.0×	271 1.7×	46 0.3×	26	1.0k
R. Todorović United States	6	575 1.8×	501 1.8×	129 0.5×	35 0.2×	152 1.2×	11	1.2k
Francesc Cabré Spain	18	293 0.9×	50 0.2×	327 1.3×	331 2.0×	99 0.8×	55	995
Timothy W. Harper United States	17	345 1.1×	45 0.2×	192 0.7×	177 1.1×	211 1.6×	30	1.0k
J. M. Fromson United Kingdom	11	102 0.3×	231 0.8×	57 0.2×	136 0.8×	163 1.2×	22	534
Maria Manuel Silva Portugal	17	403 1.3×	74 0.3×	201 0.8×	83 0.5×	66 0.5×	36	839
André Crastes de Paulet France	17	352 1.1×	163 0.6×	105 0.4×	43 0.3×	31 0.2×	35	814

Countries citing papers authored by H J Smith

Since Specialization

Citations

This map shows the geographic impact of H J Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H J Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H J Smith more than expected).

Fields of papers citing papers by H J Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H J Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H J Smith. The network helps show where H J Smith may publish in the future.

Co-authorship network of co-authors of H J Smith

This figure shows the co-authorship network connecting the top 25 collaborators of H J Smith. A scholar is included among the top collaborators of H J Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H J Smith. H J Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mason, P. R., et al.. (2003). Some 1,2-Diphenylethane Derivatives as Inhibitors of Retinoic Acid—Metabolising Enzymes. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(5). 431–443. 9 indexed citations

Nicholls, Paul J., et al.. (2002). Some Coumarins and Triphenylethene Derivatives as Inhibitors of Human Testes Microsomal 17β-hydroxysteroid Dehydrogenase (17β-HSD Type 3): Further Studies with Tamoxifen on the Rat Testes Microsomal Enzyme. Journal of Enzyme Inhibition and Medicinal Chemistry. 17(2). 93–100. 20 indexed citations

Kirby, Andrew J., et al.. (2002). Some 3-(4-Aminophenyl)pyrrolidine-2,5-diones as All- trans -retinoic Acid Metabolising Enzyme Inhibitors (RAMBAs). Journal of Enzyme Inhibition and Medicinal Chemistry. 17(5). 321–327. 12 indexed citations

Smith, H J, et al.. (2001). Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers. Expert Opinion on Therapeutic Patents. 11(5). 789–824. 64 indexed citations

Nicholls, Paul J., et al.. (2001). Inhibitors of Human and Rat Testes Microsomal 17 β-Hydroxysteroid Dehydrogenase (17β-HSD) as Potential Agents for Prostatic Cancer. Journal of enzyme inhibition. 16(1). 35–45. 21 indexed citations

Smith, H J, et al.. (1999). 1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase. Bioorganic & Medicinal Chemistry Letters. 9(14). 2105–2108. 37 indexed citations

Evans, B. A. J., et al.. (1997). Inhibitors of Type 2 5α‐Reductase from Human Genital Skin Fibroblasts Based on 3‐Phenylmethylene Pyrrolidine‐2, 5‐dione. Pharmacy and Pharmacology Communications. 3. 249–257. 1 indexed citations

Smith, H J. (1996). Design of Enzyme Inhibitors as Drugs A Review. Pharmacy and Pharmacology Communications. 2(1). 3–9. 1 indexed citations

Smith, H J, et al.. (1996). Some Flavones and Isoflavones as Inhibitors of Human Placental 17β‐Hydroxysteroid Dehydrogenase In‐vitro. Pharmacy and Pharmacology Communications. 2(1). 21–23. 1 indexed citations

10.

Pepper, Chris, et al.. (1994). Racemisation of drug enantiomers by benzylic proton abstraction at physiological pH. Chirality. 6(5). 400–404. 20 indexed citations

11.

Smith, H J, et al.. (1993). 6 Inhibitors of Enkephalin-degrading Enzymes as Potential Therapeutic Agents. Progress in medicinal chemistry. 30. 327–378. 5 indexed citations

12.

Whomsley, Rhys, et al.. (1993). Substituted 1-[(benzofuran-2-YL)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 44(4-6). 675–676. 41 indexed citations

13.

Whomsley, Rhys, et al.. (1993). Some 1-, and 3-Substituted 3-(4 - Aminophenyl)Pyrrolidine-2,5-Diones as Selective Inhibitors of Aromatase. Journal of enzyme inhibition. 6(4). 317–330. 7 indexed citations

14.

Smith, H J, et al.. (1992). Novel Inhibitors of Enkephalin-Degrading Enzymes IV: Structure-Activity Relationships within the Penicillins as Enkephalinase Inhibitors. Journal of enzyme inhibition. 6(2). 165–173. 1 indexed citations

15.

Sewell, Robert D. E., et al.. (1989). Novel Inhibitors of Enkephalin-Degrading Enzymes I: Inhibitors of Enkephalinase by Penicillins. Journal of enzyme inhibition. 3(2). 91–101. 5 indexed citations

16.

Smith, H J, et al.. (1988). Structure-Activity Relationships for Non-Steroidal Inhibitors of Aromatase. Journal of enzyme inhibition. 2(3). 215–229. 29 indexed citations

17.

Sewell, Robert D. E., et al.. (1988). Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan. Psychopharmacology. 94(4). 540–544. 14 indexed citations

18.

Shaw, Michael, Paul J. Nicholls, & H J Smith. (1988). Aminoglutethimide and ketoconazole: Historical perspectives and future prospects. Journal of Steroid Biochemistry. 31(1). 137–146. 39 indexed citations

19.

Nicholls, Paul J., et al.. (1971). Potential irreversible inhibitors of acetylcholinesterase:N-trimethyl-N‘-iodoacetyl diaminoalkane iodides. Journal of Pharmacy and Pharmacology. 23(11). 865–867.

20.

Smith, H J, et al.. (1971). Biological Sciences: Polymers Formed by some β-Lactam Antibiotics. Nature. 232(5305). 45–46. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact